Market Analysis and Insights: Global Biosimilar Testing and Development Services Market
The global Biosimilar Testing and Development Services market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified into effector binding, ELISA, kinetic binding assays, and ADCC & CDC cell-based assays.
Report Includes
This report presents an overview of global market for Biosimilar Testing and Development Services market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Biosimilar Testing and Development Services, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Biosimilar Testing and Development Services, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biosimilar Testing and Development Services revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Biosimilar Testing and Development Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Biosimilar Testing and Development Services revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Eurofins Scientific, SGS, Charles River Laboratories, Pharmaceutical Product Development, Exova, Source BioScience, Intertek Group, Medistri and Pace Analytical Services, etc.
By Company
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
Segment by Type
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Segment by Application
PK assay
Tiered Immunogenicity testing
NAb assays
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biosimilar Testing and Development Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosimilar Testing and Development Services companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biosimilar Testing and Development Services revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Effector Binding
1.2.3 ELISA
1.2.4 Kinetic Binding Assays
1.2.5 ADCC & CDC Cell-Based Assays
1.3 Market by Application
1.3.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 PK assay
1.3.3 Tiered Immunogenicity testing
1.3.4 NAb assays
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Testing and Development Services Market Perspective (2018-2029)
2.2 Global Biosimilar Testing and Development Services Growth Trends by Region
2.2.1 Biosimilar Testing and Development Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biosimilar Testing and Development Services Historic Market Size by Region (2018-2023)
2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Region (2024-2029)
2.3 Biosimilar Testing and Development Services Market Dynamics
2.3.1 Biosimilar Testing and Development Services Industry Trends
2.3.2 Biosimilar Testing and Development Services Market Drivers
2.3.3 Biosimilar Testing and Development Services Market Challenges
2.3.4 Biosimilar Testing and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biosimilar Testing and Development Services by Players
3.1.1 Global Biosimilar Testing and Development Services Revenue by Players (2018-2023)
3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2018-2023)
3.2 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biosimilar Testing and Development Services, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Biosimilar Testing and Development Services Market Concentration Ratio
3.4.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2022
3.5 Global Key Players of Biosimilar Testing and Development Services Head office and Area Served
3.6 Global Key Players of Biosimilar Testing and Development Services, Product and Application
3.7 Global Key Players of Biosimilar Testing and Development Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Testing and Development Services Breakdown Data by Type
4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2018-2023)
4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2024-2029)
5 Biosimilar Testing and Development Services Breakdown Data by Application
5.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2018-2023)
5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biosimilar Testing and Development Services Market Size (2018-2029)
6.2 North America Biosimilar Testing and Development Services Market Size by Type
6.2.1 North America Biosimilar Testing and Development Services Market Size by Type (2018-2023)
6.2.2 North America Biosimilar Testing and Development Services Market Size by Type (2024-2029)
6.2.3 North America Biosimilar Testing and Development Services Market Share by Type (2018-2029)
6.3 North America Biosimilar Testing and Development Services Market Size by Application
6.3.1 North America Biosimilar Testing and Development Services Market Size by Application (2018-2023)
6.3.2 North America Biosimilar Testing and Development Services Market Size by Application (2024-2029)
6.3.3 North America Biosimilar Testing and Development Services Market Share by Application (2018-2029)
6.4 North America Biosimilar Testing and Development Services Market Size by Country
6.4.1 North America Biosimilar Testing and Development Services Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Biosimilar Testing and Development Services Market Size by Country (2018-2023)
6.4.3 North America Biosimilar Testing and Development Services Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Biosimilar Testing and Development Services Market Size (2018-2029)
7.2 Europe Biosimilar Testing and Development Services Market Size by Type
7.2.1 Europe Biosimilar Testing and Development Services Market Size by Type (2018-2023)
7.2.2 Europe Biosimilar Testing and Development Services Market Size by Type (2024-2029)
7.2.3 Europe Biosimilar Testing and Development Services Market Share by Type (2018-2029)
7.3 Europe Biosimilar Testing and Development Services Market Size by Application
7.3.1 Europe Biosimilar Testing and Development Services Market Size by Application (2018-2023)
7.3.2 Europe Biosimilar Testing and Development Services Market Size by Application (2024-2029)
7.3.3 Europe Biosimilar Testing and Development Services Market Share by Application (2018-2029)
7.4 Europe Biosimilar Testing and Development Services Market Size by Country
7.4.1 Europe Biosimilar Testing and Development Services Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Biosimilar Testing and Development Services Market Size by Country (2018-2023)
7.4.3 Europe Biosimilar Testing and Development Services Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biosimilar Testing and Development Services Market Size (2018-2029)
8.2 China Biosimilar Testing and Development Services Market Size by Type
8.2.1 China Biosimilar Testing and Development Services Market Size by Type (2018-2023)
8.2.2 China Biosimilar Testing and Development Services Market Size by Type (2024-2029)
8.2.3 China Biosimilar Testing and Development Services Market Share by Type (2018-2029)
8.3 China Biosimilar Testing and Development Services Market Size by Application
8.3.1 China Biosimilar Testing and Development Services Market Size by Application (2018-2023)
8.3.2 China Biosimilar Testing and Development Services Market Size by Application (2024-2029)
8.3.3 China Biosimilar Testing and Development Services Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Biosimilar Testing and Development Services Market Size (2018-2029)
9.2 Asia Biosimilar Testing and Development Services Market Size by Type
9.2.1 Asia Biosimilar Testing and Development Services Market Size by Type (2018-2023)
9.2.2 Asia Biosimilar Testing and Development Services Market Size by Type (2024-2029)
9.2.3 Asia Biosimilar Testing and Development Services Market Share by Type (2018-2029)
9.3 Asia Biosimilar Testing and Development Services Market Size by Application
9.3.1 Asia Biosimilar Testing and Development Services Market Size by Application (2018-2023)
9.3.2 Asia Biosimilar Testing and Development Services Market Size by Application (2024-2029)
9.3.3 Asia Biosimilar Testing and Development Services Market Share by Application (2018-2029)
9.4 Asia Biosimilar Testing and Development Services Market Size by Region
9.4.1 Asia Biosimilar Testing and Development Services Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Biosimilar Testing and Development Services Market Size by Region (2018-2023)
9.4.3 Asia Biosimilar Testing and Development Services Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biosimilar Testing and Development Services Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Biosimilar Testing and Development Services Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biosimilar Testing and Development Services Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Biosimilar Testing and Development Services Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Biosimilar Testing and Development Services Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Biosimilar Testing and Development Services Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biosimilar Testing and Development Services Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Biosimilar Testing and Development Services Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Biosimilar Testing and Development Services Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Biosimilar Testing and Development Services Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biosimilar Testing and Development Services Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Biosimilar Testing and Development Services Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Biosimilar Testing and Development Services Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
11.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.1.5 Eurofins Scientific Recent Developments
11.2 SGS
11.2.1 SGS Company Details
11.2.2 SGS Business Overview
11.2.3 SGS Biosimilar Testing and Development Services Introduction
11.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.2.5 SGS Recent Developments
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
11.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.3.5 Charles River Laboratories Recent Developments
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Details
11.4.2 Pharmaceutical Product Development Business Overview
11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
11.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.4.5 Pharmaceutical Product Development Recent Developments
11.5 Exova
11.5.1 Exova Company Details
11.5.2 Exova Business Overview
11.5.3 Exova Biosimilar Testing and Development Services Introduction
11.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.5.5 Exova Recent Developments
11.6 Source BioScience
11.6.1 Source BioScience Company Details
11.6.2 Source BioScience Business Overview
11.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
11.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.6.5 Source BioScience Recent Developments
11.7 Intertek Group
11.7.1 Intertek Group Company Details
11.7.2 Intertek Group Business Overview
11.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
11.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.7.5 Intertek Group Recent Developments
11.8 Medistri
11.8.1 Medistri Company Details
11.8.2 Medistri Business Overview
11.8.3 Medistri Biosimilar Testing and Development Services Introduction
11.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.8.5 Medistri Recent Developments
11.9 Pace Analytical Services
11.9.1 Pace Analytical Services Company Details
11.9.2 Pace Analytical Services Business Overview
11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
11.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.9.5 Pace Analytical Services Recent Developments
11.10 Sigma-Aldrich
11.10.1 Sigma-Aldrich Company Details
11.10.2 Sigma-Aldrich Business Overview
11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
11.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2018-2023)
11.10.5 Sigma-Aldrich Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
听
听
*If Applicable.
